List of news
-
Featured news story
Published on: 23 March 2026
UCLH have recruited the first participant in the world to a new global phase I study for early Alzheimer’s Disease (AD).
-
Category: Charity news
Published on: 10 April 2026
The UCLH HLH team recently led a national forum focusing on establishing local and regional teams for the care of patients with this life-threatening and under-diagnosed condition.
-
Category: Charity news
Published on: 07 April 2026
We are delighted to have our largest ever team of runners taking part in this Sunday’s London Landmarks Half Marathon.
-
Category: UCLH news
Published on: 07 April 2026
-
Category: Research news
Published on: 02 April 2026
A clinical trial at UCLH is investigating whether adding a targeted cancer drug called adagrasib to standard first-line immunotherapy and chemotherapy can delay disease progression in people with advanced non-small cell lung cancer (NSCLC) – the most common type of lung cancer.
-
Category: UCLH news
Published on: 02 April 2026
There is industrial action by resident doctors from 7am on Tuesday 7 April until 6.59am on Monday 13 April.
-
Category: UCLH news
Published on: 26 March 2026
A pioneering project at the Royal National ENT and Eastman Dental Hospitals (RNENTEDH) has led to a dramatic reduction in greenhouse gas emissions from dental sedation – without any impact on patient care.
-
Category: UCLH news
Published on: 25 March 2026
UCLH has jointly two clinical leads, Dr Melissa Heightman and Dr Dee Hora, to the post of strategic clinical director.
-
Category: UCLH news
Published on: 24 March 2026
Using artificial intelligence tools to read thousands of chest X-rays and prioritise abnormal ones did not lead to faster lung cancer diagnoses, according to a new study led by researchers from UCLH, UCL and the University of Nottingham.
-
Category: UCLH news
Published on: 12 March 2026
-
Category: UCLH news
Published on: 11 March 2026
Clinician researchers at UCLH and UCL are leading a major UK clinical trial to test whether proton beam therapy (PBT) can significantly improve survival for patients with mesothelioma, a rare and aggressive cancer of the lining of the lung.
